Promethera Biosciences logo

Promethera Biosciences

Promethera Biosciences is a biotechnology company developing regenerative medicine treatments for liver diseases.

5

Funding Rounds

$103.1m

Money raised

Overview

Promethera Biosciences is a biotechnology company developing regenerative medicine treatments for liver diseases.

Funding

Funding series

Funding Series Analysis

The company Promethera Biosciences has raised a total of $103.08m in funding over 5 rounds.

Key Insights:

  • Promethera Biosciences Series D round, December 2019: $8.4m
  • Promethera Biosciences Series D round, May 2019: $44.4m
  • Promothera , April 2018: $11.5m
  • Promethera Biosciences Series B round: $31.48m
  • Promethera Biosciences Series A round: $7.3m
Promethera Biosciences logo
Promethera Biosciences Series D round, December 2019 $8.4m
Promethera Biosciences logo
Promethera Biosciences Series D round, May 2019 $44.4m
Promethera Biosciences logo
Promothera , April 2018 $11.5m
Promethera Biosciences logo
Promethera Biosciences Series B round $31.48m
Promethera Biosciences logo
Promethera Biosciences Series A round $7.3m